Effect of Exercise and Salvia officinalis on Postmenopausal Women

Preventive effects of Exercise Training and Salvia officinalis on Inflammation and Insulin Resistance in Postmenopausal Women

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140415017288N9

Enrollment

Registered

2023-02-03

Start date

2023-01-05

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Postmenopausal Women. Condition 2: Insulin resistance. Postmenopausal Impaired glucose tolerance (oral)

Interventions

Intervention 1: Control group: This group received three 100 mg starch tablets as a placebo during the 8-week intervention period. Intervention 2: Intervention group 1: Training group (in this group f

Eligibility

Sex/Gender

Female

Age

50 Years to 65 Years

Inclusion criteria

Inclusion criteria: being menopausal Age range 50-65 years Inactive lifestyle (exercise less than 1 hour per week) Not taking medicine in the last 6 months. Being willing to participate in the study.

Exclusion criteria

Exclusion criteria: Supplement use. Diagnosis of other diseases during the implementation of the protocol. Not taking Salvia officinalis. Use of estrogen and other androgens and steroids that affect estrogen receptors.

Design outcomes

Primary

Measure	Time frame
Tumor Necrosis Factor Alpha. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;Interleukin-10. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;Interleukin-12. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;Fasting blood glucose. Timepoint: Before and after the protocol. Method of measurement: Biochemical methods.;Fasting blood insulin. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;Insulin resistance index (HOMA-IR). Timepoint: Before and after the protocol. Method of measurement: formulas.	—

Measure

Time frame

Tumor Necrosis Factor Alpha. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;Interleukin-10. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;Interleukin-12. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;Fasting blood glucose. Timepoint: Before and after the protocol. Method of measurement: Biochemical methods.;Fasting blood insulin. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;Insulin resistance index (HOMA-IR). Timepoint: Before and after the protocol. Method of measurement: formulas.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Abdi

Islamic Azad University

a.abdi@iauamol.ac.ir+98 11 4321 7124

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026